Literature DB >> 3513819

The relation of exposure time and drug concentration in their effect on cloning efficiency after incubation of human bone marrow with cytosine arabinoside.

R Raijmakers, T de Witte, P Linssen, J Wessels, C Haanen.   

Abstract

The effect of different cytosine arabinoside (Ara-C) concentrations and exposure times upon clonogenicity of normal bone marrow cells was studied. One hour incubation, even at the pharmacologically high Ara-C concentration of 10(-5) M, was not cytotoxic. Prolonged incubation resulted in a very great increase in Ara-C cytotoxicity, provided that inactivation of Ara-C by deamination was limited. The results show that long-term exposure to Ara-C, even at pharmacologically very low concentrations, is deleterious to clonogenic cells and provide an experimental basis for the reported therapeutic efficacy of long-term low dose Ara-C administration in leukaemia and preleukaemic syndromes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513819     DOI: 10.1111/j.1365-2141.1986.tb02956.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.

Authors:  Surasak Phuphanich; Bernard Maria; Rene Braeckman; Marc Chamberlain
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

2.  In vitro characterization of the myelotoxicity of cyclopentenyl cytosine.

Authors:  D A Volpe; D L Du; C K Grieshaber; M J Murphy
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

4.  In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.

Authors:  N Van der Lely; T De Witte; J Wessels; R Raymakers; P Muus; F Preijers
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

5.  Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study.

Authors:  Daniel Shepshelovich; Yonatan Edel; Hadar Goldvaser; Tal Dujovny; Ofir Wolach; Pia Raanani
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

6.  Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.

Authors:  Jan-Paul Bohn; Vera Reinstadler; Georg Pall; Günther Stockhammer; Michael Steurer; Herbert Oberacher; Dominik Wolf
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.